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 التنبؤ بجودة الحياة لدى مرضى ارتفاع ضغط الدم والجلطة الدماغية
 هدفـت هـذه الدراسة إلى التعرف على جودة الحياة بين مرضى ارتفاع ضغط الدم ومرضى :ملخـص 
مريضاً مصاباً بارتفاع ضغط الدم والجلطة الدماغية باإلضافة إلى ) 112(الجلطة الدماغية، وشملت العينة 
هم ارتفاع ضغط دم حيث اعتبرت كمجموعة ضابطة، ولتحقيق أهداف الدراسة استخدم مريضاً لدي ) 224(
واآلخر لقياس مدى االلتزام بالنظام ) WHO-QOL(الباحـثون مقياسـيين أحدهمـا لقياس جودة الحياة 
 واستخدم الباحثون عدة أساليب إحصائية ةالدوائـي وغير الدوائي وذلك من خالل استخدام حاالت مقارني 
المتوسطات الحسابية، النسب، اختبار التباين األحادي، ونماذج اإلنحدار النسبي، وتوصلت الدراسة مـنها 
إلـى أن جـودة الحياة كانت أضعف لدى مرضى ارتفاع ضغط الدم ممن لديهم جلطة دماغية مقارنةً مع 
 الحياة بين مرضـى ارتفـاع ضغط الدم بدون جلطة دماغية وكانت العوامل التالية قوية للتنبؤ عن جودة 
 :أفراد العينة حسب الترتيب التالي
الجـنس، المتابعة الصحية، الطعام، التمارين الرياضية، وأخيراً مستوى الضغط النفسي، وقد بين نموذج 
االنحـدار النسبي أن مستوى الضغط النفسي المنخفض بين الرجال اللذين لديهم ارتفاع في ضغط الدم له 
جاالت جودة الحياة، وخلصت الدراسة إلى أن االلتزام بالنظام الدوائي وغير األثـر القوي للتنبؤ بجميع م 
الدوائـي مرتـبط بقـوة بجودة حياة أفضل لدى كل من مرضى ارتفاع ضغط الدم والجلطة الدماغية أو 
 .مرضى ارتفاع ضغط الدم فقط
Abstract: Compliance with the pharmacological and non-pharmacological 
therapeutic regimen is essential to prevent occurrence and worsening hypertension 
and stroke. This study aimed at the identification of predictors of Quality of Life 
(QOL) among hypertensive patients without stroke and hypertensive patients with 
stroke. Self-reported QOL was obtained from 112 patients with hypertension and 
stroke and 224 patients with hypertension only with the WHO-QOL-BREF 
questionnaire and compliance with the pharmacological and non-pharmacological 
therapeutic regimen was assessed with a standardized questionnaire. Means of 
QOL were compared with ANOVA procedures and predictors were estimated 
using multiple linear regression models. The results of this study showed that self-
reported QOL is poorer in patients with stroke than in hypertensive patients. Male 
gender appears to be a strong predictor of quality of life in patients either with 
hypertension or stroke. Follow up health care programmes are essential for good 
quality of life among both patient groups. Diet, physical exercise, low level of 
stress are important factors for enhanced QOL. Current smoking seems to enhance 
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the psychological and social dimensions for both patients groups. Multiple linear 
regression models indicate that low level of stress and male gender are genuine 
predictors of all dimensions of QOL among hypertensive patients, but not in stroke 
patients. It is concluded in this study that compliance with the pharmacological 
and non-pharmacological therapeutic regimen is strongly linked with a better QOL 
among patients with stroke and hypertension or hypertension only. 
Key word: quality of life, hypertension, stroke, compliance 
 
Introduction 
Hypertension is the most prevalent health problem among adult primary 
care patients, but its recognition and treatment are suboptimal. Although 
awareness about the disease has improved in the past two decades, the 
reality is that many people remain untreated or not adequately controlled. 
The treatment of hypertension is usually long term, and its success will 
depend on the effects of the drug regimen on the patient's quality of life 
[1/462-465]. Optimal therapy requires careful attention to patients' age, sex, 
race, diet, exercise, tobacco use, co-morbid conditions, choice of 
antihypertensive drug treatment, compliance with treatment, and 
achievement of blood pressure control [2/794-801]. The use of health-
related quality of life assessment in antihypertensive studies and in routine 
clinical practice provides another opportunity to optimize a patient's 
regimen for short- and long-term hypertension control in a cost-effective 
manner [3/510-514].  
Drug properties, including mechanism of action and pharmacokinetics, have 
been shown to influence the impact of drug side effects and the degree to 
which patients tolerate therapy. Researchers have attempted to standardize 
the construct of quality of life to have broad applications in health care 
policy and management; however, clinical research in hypertension should 
focus on the components of health-related quality of life that influence 
patient outcomes with regard to behaviours affecting adherence. 
Antihypertensive agents that maximize patient acceptance and quality of life 
are now available. Future quality-of-life research should be directed toward 
learning more about human behaviour so that adherence to non-
pharmacologic interventions such as diet and exercise will be enhanced 
[4/530-537]. 
Little empirical based data has been obtained as to whether 
pharmacological, non-pharmacological treatment options, life-style and 
regular health care follow-up are associated with enhanced quality of life 
either in hypertensive patients and patients with stroke. In this study we 
measured quality of life, compliance with the pharmacological and non-
pharmacological therapeutic regimen (diet, exercise, health care follow-up 
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and healthy life-style) either in patients with hypertension and patients with 
stroke. The goal of this study was to investigate compliance with the 
pharmacological and non-pharmacological therapeutic regimen and life-
style factors to predict quality of life either in hypertensive patients and 
patients with stroke.  
Material and Methods 
The study population of 336 patients consists of 112 subjects with stroke 
and hypertension and 224 patients with hypertension only. All patients were 
recruited from the same geographical area in Gaza Strip [5/76-77, 6/1029-
1041]. Three main hospitals in Gaza Strip (Shefa, Naser, and European 
Hospital) and the geographically and administratively related primary health 
care clinics were pinpointed for the selection of the study population. 
Patients were aged between 35 and 69 years. The study was approved by the 
ethical committee of the Ministry of Health and patients gave written 
informed consent. 
Selection of patients 
All available discharge data of patients who had been hospitalized in three 
main hospitals in Gaza Strip (Shefa, Nasser, and European Hospital) 
between 1st January and 31st December 2001 were screened for patients with 
stroke by using non-probability purposive sampling.  The response rate was 
96 percent. The total number of cases was 180 subjects with stroke and 
history of hypertension. According to exclusion criteria 68 (38%) patients 
were excluded from the study: 19 (28%) died after first stroke; eighteen 
(26%) had a second stroke; 7 subjects (10%) were over 69 years old; 10 
(15%) participated in the pilot study; 7 (10%) patients had no computer 
tomography head scan; 4 (6%) refused to participate in the study; 3 (4%) 
patients started their therapeutic regimen less than one year. Ten patients 
participating in the pilot study and test-retest study were excluded to reduce 
response bias. The main reason of exclusion of the subjects is to control for 
confounding factors and enhance the internal and external validity of the 
study. The exclusion criteria for the cases applied to the controls as well, 
subsequently to the matching process. Ultimately, 112 (62%) patients with 
stroke were selected from the registers. The diagnosis of stroke was 
confirmed by a physician and a head CT scan was performed. Stroke was 
defined as “a sudden loss of brain function resulting from disruption of the 
blood supply to a part of the brain" [7/1725-1726].   
During the same study period 224 patients with hypertension only (no 
stroke) were selected from primary health care clinics related to the three 
main hospitals in Gaza Strip. Hypertension was defined when the threshold 
levels of 140mmHg systolic and 90mmHg diastolic were reached. Diagnosis 
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was made and confirmed by a physician. Further grading into mild, 
moderate, severe hypertension was not made. All patients were selected 
only, if a history of other physical diseases (diabetes, myocardial infarction, 
atrial fibrillation, pulmonary oedema, asthma) was ruled out.  
Study design and questionnaire 
A one to two matched case-control study was carried out. The case group 
consists of 112 subjects with stroke and hypertension only, and the control 
group consists of 224 subjects with hypertension only. Cases and controls 
were matched by age, sex, starting point of therapeutic regimen for both 
pharmacological and non-pharmacological treatment, time of hypertension, 
enrollment location of hospital related health care clinics and calendar time. 
For each case two identical controls were recruited to detect small 
differences between the two groups [5/76-77] and to compensate potential 
loss of controls. The control group was selected from the same primary 
health care centers, where the cases subjects used to make medical follow-
up before the development of stroke. To test feasibility, validity and 
reliability of the instrument a small-scale study was carried out by using a 
small sample consisting of 10 cases of stroke with history of hypertension (5 
males and 5 females), and 20 patients with hypertension only as a control 
group. Minor adjustment of the questionnaire was done. Probands of the 
pilot study were excluded from the study population. 
The first part of the questionnaire gives information on age, sex, marital 
status, number of children, and socio-economic status. Quality of life 2 
weeks prior to the interview was assessed with the brief version (26-items) 
of the WHO Quality of Life Questionnaire which is a valid and reliable 
short version of the 100-item version “WHOQOL-100” [8/551-558]. This 
instrument yields five dimensions of quality of life: physical, psychological, 
social relations, environmental and global. Patients self-reported answers 
are classified into these five dimensions of quality of life on a range from 0 
(lowest) to 100 (highest) for each dimension.  
The intensity of psychological stressors two weeks prior to interview was 
assessed using five items on a 5-level scale ranging from none to very 
strong (0-4) adapted from the Symptom Check List by Derogatis (SCL-90) 
with regards to nervousness, paranoia, social phobia, criticism and 
loneliness [9]. To estimate level of stress, a sum score was created out of the 
five items. Patients scoring 8 or higher out of 20 on the five items were 
regarded as having high level of stress. All other patients were considered 
experiencing low level of stress.  
A certified translation of the questionnaire from English into Arabic 
language was performed twice independently and the results were checked 
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for inconsistencies.  
Statistical analysis 
The proportions of compliance and non-compliance with the therapeutic 
regimen were compared for both patient groups with Pearson’s Chi-square 
test. Means of quality of life are cross-tabled for all dimensions of quality of 
life and all factors of the pharmacological and non-pharmacological regimen 
stratified for both patient groups and differences in means were analysed 
with ANOVA statistics with a significance level set at p < 0.05. Multiple 
linear regressions models were applied for the analysis of predictors of 
quality of life separate for both groups of patients using backward selection. 
Each dimension of quality of life was considered as dependant variables and 
all factors of the pharmacological and non-pharmacological therapeutic 
regimen were regarded as independent variables using backward selection 
method. All multiple regression models were adjusted for covariates, such 
as age, sex, income and level of education because each single factor tended 
to show an univariate association with quality of life. 
Results 
Gender and age proportion among cases and controls is identical due to 
matching by age and sex. Males (51.8%) are only slightly more frequent 
than females in the study population (48.2%). Among the registered patients 
none was younger than 40 years and none older than 69 years of age. Two 
larger age groups (52-57 years; 58-63 years) accounted for 57% of the age 
distribution. The elder probands (64-69 years) showed a proportion of 24%. 
Probands aged 45 years old or younger were the smallest group in the study. 
Factors of compliance and non-compliance with the therapeutic regimen and 
life style factors are presented in Table 1.   Factors of compliance are listed  
in the left column. Patients answered questions with either “yes” or “no”. 
Alternative answers are classified as factors of compliance or non-
compliance with the therapeutic regimen. The results are stratified for 
patients with stroke and patients with hypertension only.  
Results show that more than 75% of stroke patients were compliant with the 
therapeutic regimen regarding medication and about 62% had regular health 
care follow-ups. Almost two-third of patients with stroke was neither 
smoker (64.3%) nor had high levels of stress (61.6%).  
In contrast, patients with hypertension show a different pattern. The 
majority of them were compliant with the therapeutic regimen 
(antihypertensive medication 95.5%), and they used diets regularly. 
Exceptional for the areas of weight reduction (15.6%) and exercise program 
(48.7%) a majority showed non-compliant behaviour. 
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Table 1: Frequencies of factors of compliance and non-compliance with 
the therapeutic regimen and life style factors among patients with 
hypertension or stroke 
 Stroke Hypertension  
Factors of compliance with 








Anti-hypertensive medication Yes  No Yes  No  
 Taking medication 










 Taking medication 









 Not running out of 
 pills even for a 







 N= 88 
(39.3%) 0.000 
Diet  No Yes  No Yes   









            Family preparing a 




















Physical exercise Yes  No Yes No  
 Regular program of 










 Involvement in 
 regular program of 










Follow-up health care Yes No Yes No  
 Regular follow-up 























Stress level No Yes No Yes  


















Obesity Yes No Yes No  









      
 
Comparing both groups we see a similar prevalence of low level of stress in 
hypertensive patients and in patients with stroke. Hypertensive patients 
(83.5%) had more often regular health care follow-up appointments than 
stroke patients (62.5%). Smoking was less prevalent in hypertensive patients 
than in patients with stroke. Proportions of all factors of compliance differ 
statistically significant (Pearson’s Chi2-test) between patients with stroke  
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and patients with hypertension. 
Quality of life is expressed in five dimensions: psychological, physiological, 
social relations, environmental and global. All dimensions of quality of life 
are statistically significant higher in patients with hypertension compared to 
stroke patients. Thus, all statistical analyses were determined to both disease 
groups. 
Table 2 presents means of quality of life dimensions by factors of gender, 
compliance, follow-up health care, diet, exercise, life style and obesity 
stratified for patients’ disease status (hypertension vs. stroke). Bold figures 
indicate statistically significant differences which are shown in detail in  
Table 3 by F-statistics of ANOVA procedure. Male patients either with 
hypertension or stroke rate quality of life statistically significant higher than 
female on all dimensions of quality of life, with an exception for male 
stroke patients who rate higher on the psychological and global dimension 
than female counterparts without statistical significance.  
Interestingly, all analyzed factors of gender, compliance with medication, 
follow-up, diet, physical exercise, and lifestyle do modify self-rated quality 
of life to a certain extend. Compliance with medication seems to be related 
with higher physiological quality of life, quality of social relations and the 
global quality of life either for patients with hypertension or stroke. 
Furthermore, regular follow-up health care improves ratings on 
psychological and environmental dimension of quality of life for both 
groups of patients, with the exception of hypertensive patients who 
associated  regular  blood  checks  with  lower  psychological  quality of life  
(Table 2 and 3). 
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* Means of quality of life dimensions on a range from 0 to 100 (0=lowest quality of life;  
100=highest quality of life); 
** M=male;  F=female;  
bold figures indicate significant differences between groups  
 
 
Table 2: Quality of life domains by compliance, follow up health care, diet, 
exercise, life style and obesity  
 
Dimensions of Quality 
of Life* 
Physiological Psychological Social 
relations  












Gender M** 70.81 44.34 70.51 42.24 75.07 54.31 65.63 49.78 69.07 48.92 
 F** 63.89 37.96 58.56 38.58 67.13 47.53 57.50 42.01 61.57 41.20 
Compliance            
No 62.14 39.92 54.58 44.05 61.67 52.08 59.38 43.86 52.50 47.32  
Medication taken 
as prescribed 
Yes 67.72 41.71 65.23 39.29 71.69 50.69 61.81 46.76 66.06 44.50 
No 70.71 40.75 61.94 44.36 67.78 50.25 65.00 44.21 62.50 46.32 
Medication taken 
at proper times 
Yes 67.24 41.48 64.95 38.78 71.49 51.39 61.47 46.83 65.67 44.71 
No 67.59 46.51 65.75 38.86 71.02 51.94 62.52 49.42 64.98 47.97 Run out of pills 
Yes 67.29 37.99 63.21 41.49 71.59 50.48 60.44 43.93 66.19 43.48 
Follow up care            
No 71.96 38.10 63.48 41.99 67.90 50.82 57.65 39.89 60.11 45.34 Regular check of 
blood Pressure  Yes 66.28 43.91 65.09 39.21 72.13 51.23 62.78 51.18 66.88 45.08 
No 72.30 36.31 63.63 39.09 68.47 49.80 61.15 40.33 63.18 46.13 Regular follow 
up appointments Yes 66.52 44.24 64.97 41.31 71.79 51.79 61.81 49.46 65.91 44.64 
Diet             
No 67.60 43.32 66.21 39.13 72.21 51.45 62.71 49.12 66.96 45.38 Excessive use of 
salt Yes 66.92 39.83 58.43 41.41 67.06 50.76 57.37 43.89 58.93 45.08 
No 67.33 39.81 62.42 41.06 70.76 49.11 60.65 42.67 64.24 42.67 Diet low in salt 
(by family) Yes 67.61 44.21 66.92 39.30 71.70 54.96 62.69 52.87 66.59 50.34 
No 66.30 42.60 64.92 39.68 71.57 53.97 62.08 48.21 65.53 52.08 Diet high in fat 
Yes 70.76 40.46 64.27 40.95 70.34 49.29 60.65 44.73 65.25 41.07 
Physical exercise            
No 66.23 40.97 63.23 40.24 70.19 50.93 60.33 45.31 64.55 44.79 Program of 
weight reduction Yes 74.18 49.11 72.98 46.88 76.90 54.17 69.11 65.63 70.36 56.25 
No 66.21 40.35 61.16 41.45 69.71 50.35 59.59 44.78 63.80 45.61 Program of 
exercise Yes 68.81 46.03 68.54 35.42 72.86 54.63 63.93 52.60 67.20 43.06 
Lifestyle            
Stress            
Low 69.34 43.44 66.20 37.40 73.06 47.09 63.07 47.75 67.96 47.09 Stress-Level 
High 64.24 39.91 62.25 42.39 68.09 53.50 59.34 44.97 61.13 44.02 
No 66.21 38.72 63.59 39.52 70.03 48.21 61.22 43.53 65.13 41.96 Current smoking  
Yes 72.10 45.49 69.01 42.06 75.69 55.75 63.48 50.22 33.67 50.60 
<30 70.09 39.64 67.49 36.11 72.53 49.44 62.16 46.46 66.48 48.33 Obesity: BMI 
≥30 65.68 41.86 62.88 42.07 70.36 51.63 61.40 45.89 64.76 44.05 
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* F= F-Statistics of ANOVA;  ** p= level of significance p<0.05;  
bold figures indicate significant differences between groups; 
 
Table 3: Comparison of means (F-Statistics) of quality of life dimensions 
by compliance, follow up health care, diet, exercise, life style and obesity 
Dimensions of Quality 
of Life 














Gender                    F 11.4 4.9 30.6 1.6 16.7 4.4 17.0 5.8 9.4 3.2 
 P 0.001 0.029 0.000 0.208 0.000 0.038 0.000 0.018 0.002 0.078 
Compliance            
F 1.2 0.3 3.7 2.1 4.3 0.1 0.2 0.6 5.2 6.3 Medication taken 
as prescribed P 0.273 0.600 0.055 0.155 0.039 0.716 0.623 0.448 0.024 0.578 
F 0.7 0.1 0.4 3.2 0.9 0.1 0.8 0.5 0.4 0.1 Medication taken 
at proper times P 0.409 0.821 0.514 0.076 0.357 0.750 0.388 0.466 0.524 0.736 
F 0.02 8.6 1.2 0.8 0.1 0.2 1.0 2.7 0.2 1.0 Run out of pills 
P 0.887 0.004 0.281 0.379 0.781 0.668 0.320 0.165 0.635 0.321 
Follow up care           
F 5.0 4.0 0.3 0.9 3.0 0.02 4.3 12.9 5.0 0.004 Regular check of 
Blood pressure P 0.027 0.047 0.568 0.340 0.087 0.901 0.040 0.000 0.026 0.953 
F 4.3 7.3 0.2 0.6 1.5 0.3 0.06 7.7 0.7 0.1 Regular follow- 
appointme enll P 0.40 0.008 0.664 0.460 0.220 0.561 0.809 0.007 0.415 0.743 
Diet             
F 0.1 1.4 7.2 1.6 4.1 0.04 4.2 2.5 6.6 0.01 Excessive use of 
salt P 0.801 0.242 0.008 0.440 0.045 0.837 0.041 0.119 0.011 0.946 
F 0.02 2.0 3.9 0.3 0.2 2.9 1.0 9.1 0.9 2.8 Diet low in salt 
(by family) P 0.893 0.159 0.05 0.571 0.641 0.094 0.316 0.003 0.343 0.099 
F 3.6 0.5 0.1 0.2 0.3 1.9 0.4 1.1 0.01 6.2 Diet high in fat 
P 0.061 0.481 0.801 0.673 0.592 0.168 0.536 0.308 0.922 0.014 
Physical exercise            
F 7.8 1.1 9.9 0.7 6.0 0.1 10.2 5.5 2.9 1.0 Program of 
weight reduction P 0.006 0.305 0.002 0.397 0.015 0.716 0.002 0.021 0.089 0.333 
F 1.5 2.1 10.8 2.4 2.5 0.9 4.6 3.1 1.8 0.2 Program of 
exercise P 0.217 0.155 0.001 0.126 0.117 0.341 0.033 0.081 0.172 0.670 
Lifestyle            
Stress            
F 5.6 1.4 2.8 2.9 5.8 3.7 3.1 0.7 7.2 0.5 Stress-Level 
P 0.019 0.234 0.097 0.094 0.017 0.057 0.078 0.415 0.008 0.497 
F 5.4 5.2 3.8 0.7 5.5 5.1 0.8 4.0 0.3 3.7 Current Smoking 
P 0.021 0.025 0.053 0.398 0.020 0.025 0.365 0.048 0.612 0.056 
Obesity: BMI F 4.3 0.4 4.0 3.4 1.1 0.3 0.1 0.02 0.5 0.8 
 P 0.038 0.506 0.048 0.068 0.291 0.558 0.715 0.878 0.495 0.389 
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Although restrictions in diet mostly have a positive influence on quality of 
life of all patients, statistical significant differences are remarkably more 
often in patients with hypertension (psychological and environmental 
dimension, social relations, global value) than in patients with stroke 
(environmental dimension and global value). Physical exercise, especially 
aiming at weight reduction, seems to improve nearly all dimensions of 
quality of life in hypertensive patients. Stroke patients seem to benefit more 
from programs of physical exercise in terms of psychological and 
environmental dimension of quality of life. Low level of stress is statistical 
significantly associated with improved quality of life (psychological 
dimension, social relations and global value) in hypertensive patients, and 
not at all in patients with stroke. Current smoking seems to enhance the 
psychological dimension of quality of life and social relations for both 
patients groups, and partly for stroke patients on the environmental 
dimension of quality of life. Hypertensive patients with obesity report 
statistically significant lower physiological and psychological quality of life 
than obese hypertensive patients. Obesity and stroke seem to be related in a 
different pattern: without statistical significance obese patients tend to rate 
higher scores on the physiological, psychological and social dimensions of 
quality of life than non-obese patients with stroke. 
Generally, patients with hypertension tend to associate certain factors of 
compliance, follow-up, diet, physical exercise and life style with higher 
quality of life stronger than patients with stroke do.  
Tables 4 and 5  present  results  of a  multiple  linear  regression  analysis  
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Table 4: Predictors of quality of life dimensions estimated by multiple linear 
regression models (backward selection) among patients with hypertension 
Dimensions of 
quality of life 
Predictors of quality of life* R T 95%-CI p 
    LL UL  
Male gender 3.2 2.5 10.4 0.002 
Diet high in fat 2.7 1.5 10.5 0.009 
Regular program of weight reduction  2.6 1.6 12.7 0.012 
Physical 
Low level of stress 
0.4 
2.6 1.3   9.4 0.010 
Male gender 5.1 6.6 14.9 0.000 
Taking medication as prescribed  2.1 0.5 20.4 0.040 
No excessive use of salt in meals 2.2 0.5 11.1 0.033 
Regular program of weight reduction  3.0 2.1 10.5 0.003 
Psychological 
Low level of stress 
0.5 
2.0 0.01   8.6 0.049 
Male gender 4.5 4.8 12.4 0.000 
Regular checks of blood pressure  2.1 0.4   9.7 0.034 
Social relations 
Low level of stress 
0.3 
2.5 1.0   8.8 0.015 
Male gender 4.0 3.9 11.7 0.000 
Regular program of weight reduction  2.5 1.3 11.9 0.015 
Environment 
Regular checks of blood pressure  
0.4 
2.6 1.6 11.0 0.009 
Male gender 2.9 2.3 11.6 0.004 
Taking medication as prescribed 2.3 1.8 24.4 0.023 
No excessive use of salt in meals 2.3 0.9 12.9 0.024 
Global 
Low level of stress 
0.4 
2.6 1.6 11.3 0.009 
R=Regression coefficient; 
T=T-Statistics; 95%-CI = 95% confidence interval; LL= lower limit; UL= upper limit; 
* All models were adjusted for age, sex, income and level of education; 
 
aiming at identifying predictors of quality of life. Searching for a best fit 
model predicting quality of life, all variables presented in Table 1 (gender, 
compliance, follow-up health care, diet, exercise, lifestyle) were regarded as 
potential predictors of quality of life dimensions. In a univariate linear 
regression analysis male gender, higher level of education and income were 
associated with increased quality of life among both patient groups. All 
factors of compliance with the pharmacological and non-pharmacological 
treatment regimen including age, gender, level of education and income as 
covariates were considered in a multiple linear regression model as 
independent variables applying backward selection. Dimensions of quality 
of life were defined as dependent variables. Table 4 shows results of the 
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Table 5: Predictors of quality of life dimensions estimated by multiple 
linear regression models (backward selection) among patients with 
stroke* 
Dimensions of 
quality of life 
Predictors of quality of life* R T 95%-CI p 
    LL UL  
Not taking medication at proper times 2.1 0.5 14.6 0.037 
Not running out of pills 3.1 3.4 15.9 0.003 
Physical 
Keeping up follow up appointments 
0.4
2.8 2.4 14.8 0.007 
Psychological No statistical significant predictors - - - - - 
Diet prepared by family 2.4 1.2 14.3 0.020 
Current smoking 3.2 4.2 17.3 0.002 
Social relations 
High level of stress 
0.4
3.0 3.5 16.6 0.003 
Male gender 2.0 0.2 12.6 0.044 
Diet prepared by family  2.1 0.3 14.2 0.040 
Environment 
Regular checks of blood pressure  
0.4
2.2 0.8 14.2 0.029 
Global No diet high in fat 0.2 2.5 2.3 19.8 0.014 
R=Regression coefficient; 
T=T-Statistics; 95%-CI = 95% confidence interval; LL= lower limit; UL= upper limit; 
* All models were adjusted for age, sex, income and level of education; 
 
 
The regression coefficients of all multiple regression models range around 
R=0.4 which is a sufficient value. An exception is the value of R=0.2 for the 
global dimension among patients with stroke. Therefore we need to be 
careful interpreting this result. A statistical significance was set at a level of 
<0.05. Male gender and low level of stress are common factors predicting 
quality of life in all domains except for the environmental dimension (male 
gender only) among patients with hypertension. Medication issues 
contribute to quality of life on the psychological and global dimension 
among hypertensive patients. All other factors contributing to quality of life 
stem from diet, follow-up health care and exercise in these patients.  
Different predictors of quality of life are found for stroke patients. 
Medication issues, follow-up appointments and physical exercise play an 
important role in predicting quality of life in these patients. Diet prepared by 
the family becomes an important predictor for social relations and 
environmental quality of life among stroke patients. No statistically 
significant model was found for factors predicting the psychological 
dimension in patients with stroke. 
Interestingly, the multiple linear regression analysis showed that age had no 
significant influence on any dimension of quality of life neither for patients 
with hypertension nor with stroke.  
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Discussion 
The aim of this study was to find predictors of quality of life among 
modifiable factors of compliance with the pharmacological and non-
pharmacological therapeutic regimen in patients with hypertension 
compared to patients with stroke. We found major differences in compliance 
with the pharmacological and non-pharmacological therapeutic regimen and 
life style among both patient groups. Hypertensive patients were more 
compliant, showed better adherence with the pharmacological and non-
pharmacological therapeutic regimen and had low risk health behaviour 
(smoking, obesity) compared to stroke patients.  
With regards to the pharmacological regimen, these study results are similar 
to a study by Beto et al. who reported beneficial effects of antihypertensive 
drugs on quality of life [10/125-133]. However, the many antihypertensive 
drug treatments now available have varying impact on quality of life, which 
should be taken into account when developing a rational approach to 
antihypertensive intervention in the elderly patient [11/26-39]. Nevertheless, 
these positive results need to be discussed controversial in light of 
methodological issues and limitations in studies on quality of life in 
hypertension. Physicians generally are guided in their selection of a 
particular drug for a particular patient by results of clinical trials. A claim to 
clinical trials is still difficult to achieve with quality of life studies 
pertaining to drug management of hypertension. Few studies have been 
done, and some do not yield clear results. One needs to study carefully the 
duration of the trial, the validation of the quality of life instruments used, the 
approach to confounding factors such as inclusion and stratification by 
decade of life, inclusion of females in requisite numbers and prior 
symptoms of patients who, more likely than not, suffer from a host of 
intercurrent diseases and have been placed on multiple drugs [12/113-121].  
In this study we tried to reduce the potential influence of some of these 
limitations by selecting patients without a history of other physical diseases 
(diabetes, myocardial infarction, atrial fibrillation, pulmonary oedema, 
asthma). The fact that we did not exclude patients suffering from psychiatric 
diseases such as depression is a source of selection bias in this study.  
Another main finding of this study was that patients with hypertension rated 
quality of life higher on all dimensions than stroke patients. This is most 
likely related to the physically and psychologically disabling consequences 
of stroke on all areas of life. Dam reported that depression occurs more 
often in patients with stroke than in healthy controls [13/287-293]. Since 
depressed post-stroke patients experience more impairment of concentration 
and memory function than non-depressed stroke patients this might have an 
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impact on self-reported quality of life [13/287-293, 14/696-705]. In this 
study we could not differentiate for depressed and non-depressed stroke 
patients. Depression and negative thinking on life events might be a reason 
for the difference of self-rated quality of life between stroke and 
hypertensive patients observed in this sample. Future studies on quality of 
life in hypertension and stroke would need to address psychological and 
psychiatric co-morbidity as important covariates. 
Another explanation for the differences between stroke patients might be 
related to the onset of stroke. The studied patients were may be not well 
adapted to their first stroke that had occurred during the study year 
(inclusion criteria). Thus, these results on quality of life of stroke patients 
could be different in patients with onset of stroke longer than one year 
before interview. This study lacks the exact period of time between onset of 
stroke and measurement of quality of life which would be important for an 
estimation of the impact of length of time after stroke on quality of life. 
In hypertensive patients we found a different set of factors of compliance 
and life style associated with enhanced quality of life than in stroke patients. 
Results of this study suggest that hypertensive patients make most use of 
non-pharmacological therapeutic interventions (diet, exercise) and regular 
health care follow-ups in terms of good quality of life. This result matches 
with studies supporting a major role for lifestyle interventions as the initial 
treatment for stage 1 hypertension [15/378-388]. Grimm et al. showed that 
not only weight loss is associated with an improvement in quality of life 
among hypertensive patients, but physical activity as well [16/8-14].  
Another disadvantage of this study is the lack of more detailed information 
on blood pressure of the hypertensive patients. These data would generate 
the possibility to relate the level of hypertension (mild, moderate, severe) to 
the use of pharmacological and non-pharmacological treatment options and 
its influence on quality of life. 
In support of the importance of non-pharmacological interventions, a 
double-blind randomized placebo controlled trial for the treatment of 
systolic hypertension in the elderly (Syst-Eur-Trial) showed that active 
treatment of systolic hypertension in the elderly patient was associated with 
an adverse impact on quality of life [17/2069-2079]. In that study patients 
receiving active treatment were more likely to report problems on the Social 
Interaction Scale than were placebo-treated patients. 
Enhanced quality of life in stroke patients seems to rely more on a belief in 
the medical system. This might be influenced by the fact that patients with 
acute stroke are in need for more intensive medical input than hypertensive 
patients without stroke. Stroke patients in this study felt physically much 
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better when following medical advice regarding regular intake of 
medication and follow-up health care. Furthermore, support from the family 
seems to have an important influence on quality of life in stroke patients.  
It appears that stroke patients may have little ability to improve quality of 
life by exercise and diet. The lack of exercise could be explained by the 
disease itself as stroke is a upper motor neuron disease and results in partly 
loss of voluntary control over motor movement [7/1725-1726]. Controversy, 
stroke patients appreciate smoking and stress as indicators of good quality 
of life in the environmental domain. The results are unexpected for both 
smoking and stress. Smoking is considered as a major risk factor of stroke 
[18/344-347] and stress increases blood pressure which is the main risk 
factor for stroke as well [19/40-42].  
Though results of this study support the notion to prevent progress of 
disease in hypertensive patients by applying all pharmacological and non-
pharmacological therapeutic options, we would advocate a focus on non-
pharmacological interventions for hypertensive patients where applicable, 
because this approach is related to good self-rated quality of life.  
These results do not support the same conclusion for stroke patients. 
Medical input seems to be very important to stroke patients’ quality of life. 
Further options to increase quality of life for stroke patients should be 
developed in health promoting programmes for these patients by addressing 
both pharmacological and non-pharmacological treatments. In future 
intervention studies, the effects of non-pharmacological therapeutic 
interventions on quality of life among stroke patients in combination with 
pharmacological approaches could be investigated more in detail. Therefore, 
aspects of patient well-being, including physical, emotional, and social 
status, should become important treatment considerations, which can be 
achieved by a patient-specific approach [12/113-121]. 
Conclusions 
Quality of life is a complex measure. Better compliance with the therapeutic 
regimen seems to enhance quality of life and vice versa for patients with 
stroke and hypertension or with hypertension only. As implication for 
clinical practice, health professionals should promote compliance and 
healthy life styles aiming at increasing quality of life and compliance with 
the therapeutic regimen for these patient groups. 
Recommendations 
Healthy lifestyles, patient education, family counseling, and social support 
networks should be strengthened in health promotion programs in order to 
enhance compliance with the therapeutic regimen and to improve quality of 
life. 
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